Uploaded December 2021 | Updated September 2026, 2 weeks ago
A next generation novel synthetic library was designed to find highly potent nanobodies that are both easier to manufacture and more accessible to certain proteins and smaller tissues than conventional antibodies. This particular Antibody Therapeutic for SARS-CoV-2 is modular and can be engineered to bind to multiple different places on the virus and induce a more effective immune response. Given as a therapeutic, antibodies can work right away to stimulate the immune response and cause clearance of infected cells. Furthermore, if someone is already infected with the virus, this can still help block more virus from getting in but also cause the body to recognize and eliminate infected cells. The library screening process is also very rapid, which helps identify nanobodies that bind to variants.
SAND2021-7080 V
A next generation novel synthetic library was designed to find highly potent nanobodies that are both easier to manufacture and more accessible to certain proteins and smaller tissues than conventional antibodies. This particular Antibody Therapeutic for SARS-CoV-2 is modular and can be engineered to bind to multiple different places on the virus and induce a more effective immune response. Given as a therapeutic, antibodies can work right away to stimulate the immune response and cause clearance of infected cells. Furthermore, if someone is already infected with the virus, this can still help block more virus from getting in but also cause the body to recognize and eliminate infected cells. The library screening process is also very rapid, which helps identify nanobodies that bind to variants.
SAND2021-7080 V
